6 completed, 1 withdrawn. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Atopic Asthma: new trials by email Literature Review of Atopic Asthma trials Research Report on Atopic Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC) ADX-629, Placebo - Atopic Asthma | Phase 2 | Completed | Aldeyra Therapeutics, Inc. | 8 | 2021-01-09 | 2025-02-17 |
| Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects Blood sample, POCT device - Atopic Asthma | Phase 2 | Completed | Novartis Pharmaceuticals | 193 | 2016-03-01 | 2016-11-15 |
| A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma AXP1275, AXP1275 matching placebo - Atopic Asthma | Phase 2 | Completed | Axikin Pharmaceuticals, Inc. | 21 | 2013-08-01 | 2016-02-05 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma ADC3680B oral, Placebo oral - Atopic Asthma | Phase 2 | Completed | Pulmagen Therapeutics | 36 | 2011-09-01 | 2012-02-20 |
| Randomized Controlled Trial of Silymarin in Asthma Oral Silymarin, Oral Silymarin, maintenance dose, Placebo - Atopic Asthma | Phase 2 / Phase 3 | Withdrawn | Vanderbilt University | 2010-09-01 | 2014-02-24 | |
| Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects senicapoc, Placebo - Atopic Asthma | Phase 2 | Completed | Icagen | 34 | 2008-10-01 | 2011-07-14 |
| The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics abatacept, Placebo - Atopic Asthma | Phase 2 | Completed | Washington University School of Medicine | 24 | 2008-10-01 | 2014-02-05 |
Asthma (4) · Hypersensitivity (1) · Inflammation (1)
Bronchial Diseases (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Lung Diseases (4) · Lung Diseases, Obstructive (4) · Respiratory Hypersensitivity (4) · Respiratory Tract Diseases (4) · Hypersensitivity (3) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
ADX-629 (1) · AXP1275 (1) · Abatacept (1) · Blood Specimen Collection (1) · Silymarin (1) · milk-thistle extract (1) · senicapoc (1)
Aldeyra Therapeutics, Inc. (1) · Axikin Pharmaceuticals, Inc. (1) · Icagen (1) · Novartis Pharmaceuticals (1) · Pulmagen Therapeutics (1) · Vanderbilt University (1) · Washington University School of Medicine (1)
United Kingdom (3) · Canada (2) · United States (2) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1)
Jonathan Green, MD (1) · Louis-Philippe Boulet, MD (1) · Mark Fitzgerald, MD (1) · Paul O'Byrne, MD (1) · Tak H Lee, FRCP (1) · Tina V. Hartert, MD, MPH (1)